These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3274347)

  • 1. Abrogation of cyclosporine/transfusion-induced enhancement of rabbit skin allografts by increased cyclosporine dosage.
    Smit WJ; Masendycz PJ; Dumble LJ; Francis DM; Clunie GJ
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1427-8. PubMed ID: 3274347
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclosporine dosage requirements for rabbit skin allograft enhancement due to perioperative blood transfusion and cyclosporine synergy.
    Masendycz PJ; Dumble LJ; Francis DM; Clunie GJ
    Transplant Proc; 1987 Apr; 19(2):2895-7. PubMed ID: 3551232
    [No Abstract]   [Full Text] [Related]  

  • 3. Pretransplant transfusion and cyclosporine-induced enhancement of rabbit skin allografts: donor-specific versus third-party blood.
    Dieperink H
    Transplantation; 1985 Jun; 39(6):688. PubMed ID: 3890300
    [No Abstract]   [Full Text] [Related]  

  • 4. Low-dose azathioprine is synergistic with low-dose cyclosporine in rabbit skin allograft survival.
    Friedman AL; Schiffman G; Josephson AS; Coburger LE; Friedman EA
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1270-1. PubMed ID: 3274317
    [No Abstract]   [Full Text] [Related]  

  • 5. Prolongation of related rabbit skin allografts by preoperative treatment with donor-specific or third-party transfusion and cyclosporine.
    Dumble LJ; Masendycz P; Mottram PL; Francis DM; Clunie GJ
    Transplant Proc; 1986 Apr; 18(2):355-6. PubMed ID: 3515672
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclosporine regulation of blood transfusion sensitizing and enhancing potential in rabbit skin allograft recipients.
    Smit WJ; Dumble LJ; Francis DM; Clunie GJ
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):1105-9. PubMed ID: 3291220
    [No Abstract]   [Full Text] [Related]  

  • 7. Enhancement of renal allografts by simultaneous cyclosporine and donor-specific blood transfusion.
    Francis DM; Masendycz PJ; Dumble LJ; Clunie GJ
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1464-6. PubMed ID: 3274356
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyclosporine and murine responses to alloantigens: effects of cyclosporine and donor-specific transfusions on delayed hypersensitivity reactions and murine skin allografts.
    Mottram PL; Mirisklavos A; Clunie GJ
    Transplant Proc; 1985 Apr; 17(2):1646-9. PubMed ID: 3885498
    [No Abstract]   [Full Text] [Related]  

  • 9. Synergistic effect of cyclosporine A, cyclophosphamide, and steroids in rabbit-to-rat skin xenotransplantation.
    Steinbruchel D; Kemp E; Starklint H; Dieperink H
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1168-70. PubMed ID: 3274302
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term residual cyclosporine levels following short-term administration in various allograft models demonstrating extensive survival prolongation.
    Hewitt CW; Black KS; Gonzalez GA; Dowdy SF; Reyes M; Martin DC; Achauer BM
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1244-5. PubMed ID: 3274310
    [No Abstract]   [Full Text] [Related]  

  • 11. Cyclosporine inhibits nonspecific transfusion-induced immunity in dogs.
    Kyriakides GK; Esquenazi V; Olson L; Milgrom M; Miller J
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1432-3. PubMed ID: 2978877
    [No Abstract]   [Full Text] [Related]  

  • 12. Examination of sex-associated differences and organ specificities in the survival of cardiac and skin allografts in rats treated with cyclosporine.
    Enosawa S; Hirasawa K
    Transplantation; 1989 Oct; 48(4):714-7. PubMed ID: 2799934
    [No Abstract]   [Full Text] [Related]  

  • 13. Pretransplant transfusion and cyclosporine-induced enhancement of rabbit skin allografts. Donor-specific versus third-party blood.
    King HP; Clunie GJ; Dumble LJ
    Transplantation; 1984 Apr; 37(4):418-9. PubMed ID: 6369674
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term skin allograft survival by combined therapy with suboptimal dose of cyclosporine and ribavirin.
    Jolley WB; Sharma B; Chami R; Ng C; Bullington R
    Transplant Proc; 1988 Aug; 20(4):703-6. PubMed ID: 3043841
    [No Abstract]   [Full Text] [Related]  

  • 15. Enhancement of rabbit skin allograft survival by pretransplant and peroperative hepatic antigen treatments.
    Mitchell SV; Dumble LJ; Plenter RJ; Millar RJ; Clunie GJ
    Transplant Proc; 1990 Oct; 22(5):2097-8. PubMed ID: 2219306
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyclosporine-induced long-term allograft survival and its potential in posttrauma tissue replacement.
    Black KS; Hewitt CW; Henson LE; Chau LC; Pizzo L; Achauer BM
    J Burn Care Rehabil; 1987; 8(6):531-5. PubMed ID: 3325513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined effect of low-dose FK 506 and cyclosporine A on skin graft survival.
    Dammeijer PF; Stevens HP; Hovius SE; Marquet RL
    Transplant Proc; 1990 Aug; 22(4):1653-4. PubMed ID: 1697116
    [No Abstract]   [Full Text] [Related]  

  • 18. Difficulty in the induction of tolerance to vascularised skin allografts.
    Lim SM; Li SQ; Poh LH; Chong TW
    Transplant Proc; 1994 Aug; 26(4):1957. PubMed ID: 8066633
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative study of toxicity and efficacy of cyclosporine, cyclosporine G (OG37), FK 506, and rapamycin in BALB/c mice with fitted skin grafts.
    Masri MA
    Transplant Proc; 1995 Feb; 27(1):366. PubMed ID: 7533412
    [No Abstract]   [Full Text] [Related]  

  • 20. Cyclosporine. Effects on wound healing, composite grafts, skin, cornea, and vein allografts.
    Transplant Proc; 1983 Dec; 15(4 Suppl 1-2):3051-93. PubMed ID: 6665863
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.